[1] International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sulli-van PF, Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 2009, 460(7256): 748-752.
[2] Zhong NN, Zhang R, Qiu C, Yan H, Valenzuela RK, Zhang H, Kang WH, Lu SM, Guo TW, Ma J. A novel replicated association between FXYD6 gene and schizophrenia. Biochem Bioph Res Co, 2011, 405(1): 118-121.
[3] 马捷, 樊金波, 吴胜男, 张长顺, 纪宝虎, 王磊, 李兴旺, 顾牛范, 冯国鄞, Clair DS, 贺林. 在亚洲和欧洲人群中对一个AC二核苷酸重复的多态性位点与精神分裂症的关联研究. 遗传, 2007, 29(10): 1207-1213.
[4] 李俊宁, 许琪, 沈岩, 季梁. 偏执型精神分裂症与4个涉及多巴胺代谢的基因之间的关联分析. 遗传, 2006, 28(4): 403-406.
[5] Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry, 2002, 7(4): 405-411.
[6] Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Helgason T. Genome scan meta-analysis of schizo-phrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet, 2003, 73(1): 34-48.
[7] O’Donovan MC, Williams NM, Owen MJ. Recent advances in the genetics of schizophrenia. Hum Mol Genet, 2003, 12(Suppl. 2): R125-R133.
[8] Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjorns-dottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Stefansson K. Neuregulin 1 and susceptibility to schizo-phrenia. Am J Hum Genet, 2002, 71(4): 877-892.
[9] Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA, 2003, 100(15): 8993-8998.
[10] Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Aruga J, Minabe Y, Tonegawa S, Yoshikawa T. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci USA, 2007, 104(8): 2815-2820.
[11] Lohoff FW, Weller AE, Bloch PJ, Buono RJ, Doyle GA, Ferraro TN, Berrettini WH. Association between poly-morphisms in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) on chromosome 8p and schizophrenia. Neuropsychobiology, 2008, 57(1-2): 55-60.
[12] Tabarés-Seisdedos R, Rubenstein JLR. Chromosome 8p as a potential hub for developmental neuropsychiatric disor-ders: implications for schizophrenia, autism and cancer. Mol Psychiatry, 2009, 14(6): 563-589.
[13] Kim SH, Song JY, Joo EJ, Lee KY, Ahn YM, Kim YS. EGR3 as a potential susceptibility gene for schizophrenia in Korea. Am J Med Genet, 2009, 153B(7): 1355-1360.
[14] Lee SM, Vasishtha M, Prywes R. Activation and represssion of cellular immediate early genes by serum response factor cofactors. J Biol Chem, 2010, 285(29): 22036-22049.
[15] O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci, 1999, 22(4): 167-173.
[16] O'Donovan KJ, Levkovitz Y, Ahn D, Baraban JM. Func-tional comparison of Egr3 transcription factor isoforms: identification of an activation domain in the N-terminal segment absent from Egr3beta, a major isoform expressed in brain. J Neurochem, 2000, 75(4): 1352-1357.
[17] Liu BC, Zhang J, Wang L, Li XW, Wang Y, Ji J, Yang FP, Wan CL, Gao LH, Xu YF, Feng GY, He L, Zhao XZ, He G. No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. Prog Neuro-psychopharmacol Biol Psychiatry, 2010, 34(3): 506-509.
[18] Kyogoku C, Yanagi M, Nishimura K, Sugiyama D, Morinobu A, Fukut
